AstraZeneca has 25 investors holding a majority stake of 49%. Institutions own 72% and can influence market moves. Top shareholders include Capital Research and Management, BlackRock, and The Vanguard Group. Analyst sentiments and insider ownership are also important factors to consider.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing